Clinical Trials Browser

Phase 2 × methylnaltrexone × Clear all

NCT01004393 2016-02-02

Methylnaltrexone for Opioid-induced Constipation in Cancer Patients

Phase 2 Completed

12 enrolled 10 charts

Constipation, Opioid-Related Disorders, Neoplasms